Autoantibodies in patients treated for active pulmonary tuberculosis

S. B. Kasikovic-Lecic, A. Kerenji, I. Mitic, T. Ilic (Sremska Kamenica, Novi Sad, Yugoslavia)

Source: Annual Congress 2003 - Diagnosis of tuberculosis and laboratory aspects - I
Session: Diagnosis of tuberculosis and laboratory aspects - I
Session type: Thematic Poster Session
Number: 1028
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. B. Kasikovic-Lecic, A. Kerenji, I. Mitic, T. Ilic (Sremska Kamenica, Novi Sad, Yugoslavia). Autoantibodies in patients treated for active pulmonary tuberculosis. Eur Respir J 2003; 22: Suppl. 45, 1028

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 453s
Year: 2005

Endobrochites of specific genesis in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 201s
Year: 2004

The coexistance of active pulmonary tuberculosis in lung cancer patients
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007


Frequency of endobronchial tuberculosis in patients with active pulmonary tuberculosis is high
Source: Eur Respir J 2004; 24: Suppl. 48, 33s
Year: 2004

Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Lung function defects in treated pulmonary tuberculosis patients
Source: Eur Respir J 2016; 47: 352-353
Year: 2016


Lung function defects in treated pulmonary tuberculosis patients
Source: Eur Respir J 2016; 47: 351-352
Year: 2016


The profile of patients with pulmonary and extrapulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001

Antituberculous activity of fiurenizid in vitro and in patients with destructive pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 724s
Year: 2004

Activity of lysozyme in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010

Prevalence of dyspnoea in patients with treated pulmonary tuberculosis
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017

Lung function in patients cured for pulmonary tuberculosis
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Treatment effectiveness among newly diagnosed patients with expanded pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002

Treatment results in patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002

Specific features of acute renal failure in rifampicin treated patients for pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 609s
Year: 2002

Pulmonary involvement in extrapulmonary tuberculosis patients
Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis
Year: 2011

Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

The effect of smoking on successfully treated pulmonary tuberculosis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 420s
Year: 2007

The factors associated to pulmonary impairment in patients with treated tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012

Comparison of serum anti-tuberculous glycolipid antigen antibodies among the patients of tuberculous and nontuberculous pulmonary diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 340s
Year: 2001